ICD-10-CM Billable Code

K59.31

Toxic megacolon

Clinical Classification Guidelines

Medical Intelligence & Overview

Toxic megacolon is a severe complication characterized by rapid widening (dilation) of the colon and accompanying systemic toxicity. It can develop suddenly and requires prompt medical attention to prevent life-threatening conditions. This condition often arises from underlying gastrointestinal diseases, leading to significant discomfort and health risks if not treated promptly.

Causes & Symptoms

Clinical Causes: Inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease Infections from bacteria like Clostridium difficile, Shigella, or Salmonella Ischemic colitis, caused by reduced blood flow to the colon Obstructions or tumors in the colon Use of certain medications, including anticholinergics or opioids Neutropenic colitis (typhlitis) Other gastrointestinal inflammations or infections

Key Symptoms: Severe abdominal pain and tenderness Abdominal distension or bloating Fever and chills Elevated heart rate Dehydration and reduced urine output Signs of systemic toxicity such as confusion or weakness Nausea and vomiting Signs of bowel obstruction or perforation, such as sudden worsening of symptoms

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and diagnostic imaging. Healthcare providers typically use the following approaches: - Medical history and physical examination focused on abdominal tenderness and distension - Imaging tests such as abdominal X-rays or CT scans to visualize colonic dilation and rule out perforation - Laboratory tests including complete blood counts, electrolyte panels, and blood cultures to identify infection and systemic response - Endoscopy may be considered in specific cases to assess colonic inflammation but is used cautiously due to risk of perforation - Additional tests might include stool studies for infectious causes

Treatment Protocols: Managing toxic megacolon requires prompt medical intervention with the goal of stabilizing the patient and treating the underlying cause. Typical treatments include: - Hospitalization with close monitoring - Intravenous fluids and electrolytes to address dehydration and imbalance - NPO (nothing by mouth) status to rest the bowel - Broad-spectrum antibiotics if an infectious process is identified or suspected - Corticosteroids or other medications to reduce inflammation in cases related to inflammatory bowel diseases - Decompressive procedures, such as rectal tubes or colonoscopy, may be used to reduce distension - Surgical intervention, including colectomy, may be necessary if there is perforation, worsening symptoms, or failure of medical therapy - Supportive care, including analgesics and anti-inflammatory medications, as appropriate - Close follow-up to monitor for complications and ensure recovery

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is K59.31 a billable ICD-10 code?
Yes, K59.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report K59.31?
Clinical documentation must specify the nature of Toxic megacolon and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

toxic megacolon